Pillstats
Rx only · Solution/ Drops · Ophthalmic

Pilocarpine Hydrochloride

Brands: Vuity · Pilocarpine Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8328
US makers3 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.19$6.37$9.56$12.75Dec 2025Mar 2026Jul 2026
$11.085
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5341.1K1.6K2.1K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.7K
Rx · 2026 Q1
21K
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown5SUPPLYING
Sandoz Incunknown3SUPPLYING
AbbVie Inc.unknown2EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 24, 2026
    RESOLVEDShortage resolved: Pilocarpine Hydrochloride Ophthalmic Solution (AbbVie Inc.)

    Pilocarpine Hydrochloride Ophthalmic Solution — reported in shortage by AbbVie Inc.. Therapeutic category: Ophthalmology.

  • Mar 24, 2026
    SHORTAGEDrug shortage: Pilocarpine Hydrochloride Ophthalmic Solution (AbbVie Inc.)

    Pilocarpine Hydrochloride Ophthalmic Solution — reported in shortage by AbbVie Inc.. Therapeutic category: Ophthalmology.

  • Mar 22, 2017
    RECALLRecall (Class III): Pilocarpine Hydrochloride Ophthalmic Solution 4% , packaged in 15 mL bottles, Rx Only, Manufactured by Alcon Laboratori…

    Failed Impurities/Degradation Specifications. — Recalling firm: Novartis Pharmaceuticals Corp. — nationwide